Most Recent
A property developer suing law firm Sparke Helmore in a $1 million negligence suit has resisted a bid for $215,000 in security for costs made weeks ahead of a four-day hearing in the matter, calling the sum "excessive".
The a2 Milk Company has reached a settlement in its fight against New Zealand-based Open Country's trade mark containing the jealously guarded 'a2', with the rival dairy supplier dropping its successful application to register the mark.
Prosecutors have told a court they are nearing deals with a number of individuals accused of criminal charges in its cartel case against Vina Money Transfer.
An interlocutory decision in a class action against superannuation trustee Colonial First State Investments may have significant implications for how cases against super fund trustees are litigated in the future, says Slater & Gordon’s Jessica Zarkovic and Joel Gilbourd.
Apple has been hit with a lawsuit alleging iPhone and iPad devices sold in Australia since at least 2014 and equipped with Touch and Face ID technology infringe two patents held by a non-practicing entity.
A judge hearing a price-fixing case against steel giant BlueScope has overruled an objection to the ACCCs barrister's allegedly excessive "eye-rolling" and "scathing and sarcastic" manner during a cross-examination in which the company's general manager was accused of lying under oath.
A judge overstepped in throwing out a class action against two National Australia Bank units over alleged MySuper mismanagement because of a carveout in the Victorian Supreme Court Act which bars class actions involving trust property, an appeals court has heard.
A judge has rejected a request for further information on 'very senior' Google employees involved in a notification related to a change to Google's privacy policy which at the centre of court proceedings brought by the ACCC.
NSW Health wants to amend its defence to an underpayments class action on behalf of 24,000 junior doctors, bringing claims that the lead applicant is barred from seeking compensation for group members under industrial relations law.
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.